A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 153 participants.
Also called NCT06370715
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 153 participants
- Sponsor
- Registry
-
NCT06370715
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT06370715. Allocation not applicable; no masking; primary purpose treatment. Start 2024-04-18 (actual); primary completion 2025-09-02 (actual). Results posted on 2026-09-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Insulin Lispro-aabc
- Intervention (Drug)
- Insulin Glargine
- Lead sponsor
- Eli Lilly and Company
- Collaborator
- Cipla Ltd.
Record details
- Record id
cardio:ct-nct06370715- Content hash
975bd976b14d4c0da1266022bdff4aaa9106466025b8c7b724677bf995a36a21